newsfilter
← Latest News
GlobeNewswire·

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

ROCKVILLE, MD, Oct. 29, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the